These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 334068)

  • 1. Drug resistance in Streptococcus pyogenes isolated in Japan.
    Nakae M; Murai T; Kaneko Y; Mitsuhashi S
    Antimicrob Agents Chemother; 1977 Sep; 12(3):427-8. PubMed ID: 334068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan.
    Maruyama S; Yoshioka H; Fujita K; Takimoto M; Satake Y
    Am J Dis Child; 1979 Nov; 133(11):1143-5. PubMed ID: 389035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominant role of msr(D) over mef(A) in macrolide resistance in Streptococcus pyogenes.
    Zhang Y; Tatsuno I; Okada R; Hata N; Matsumoto M; Isaka M; Isobe KI; Hasegawa T
    Microbiology (Reading); 2016 Jan; 162(1):46-52. PubMed ID: 26531240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study.
    Betriu C; Casado MC; Gómez M; Sanchez A; Palau ML; Picazo JJ
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):255-60. PubMed ID: 10212752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transduction of drug resistance to tetracycline, chloramphenicol, macrolides, lincomycin and clindamycin with phages induced from Streptococcus pyogenes.
    Ubukata K; Konno M; Fujii R
    J Antibiot (Tokyo); 1975 Sep; 28(9):681-8. PubMed ID: 1102514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.
    Liu X; Shen X; Chang H; Huang G; Fu Z; Zheng Y; Wang L; Li C; Liu L; Shen Y; Yang Y
    Pediatr Pulmonol; 2009 May; 44(5):436-41. PubMed ID: 19360846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide resistance in Streptococcus pyogenes and its correlation with T-type.
    Yamada T; Kosakai N
    Jpn Circ J; 1982 Nov; 46(11):1176-9. PubMed ID: 6752452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible and constitutive resistance to macrolide antibiotics and lincomycin in clinically isolated strains of Streptococcus pyogenes.
    Hyder SL; Streitfeld MM
    Antimicrob Agents Chemother; 1973 Sep; 4(3):327-31. PubMed ID: 4586147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emergence of erythromycin-resistant Streptococcus pyogenes in Seoul, Korea.
    Cha S; Lee H; Lee K; Hwang K; Bae S; Lee Y
    J Infect Chemother; 2001 Jun; 7(2):81-6. PubMed ID: 11455497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of penicillin-macrolide-resistant Streptococcus pyogenes among pet animals: An ongoing public health threat.
    Samir A; Abdel-Moein KA; Zaher HM
    Comp Immunol Microbiol Infect Dis; 2020 Feb; 68():101390. PubMed ID: 31760363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of antimicrobial susceptibility of clinical isolates of Streptococcus pyogenes in Japan: report of a countrywide surveillance study.
    Hotomi M; Billal DS; Shimada J; Yamauchi K; Fujihara K; Yamanaka N;
    J Infect Chemother; 2005 Feb; 11(1):48-51. PubMed ID: 15729489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromycin resistance of Streptococcus pyogenes in Madrid.
    Orden B; Perez-Trallero E; Montes M; Martínez R
    Pediatr Infect Dis J; 1998 Jun; 17(6):470-3. PubMed ID: 9655536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of group A beta-hemolytic streptococci to thirteen antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997.
    Kaplan EL; Johnson DR; Del Rosario MC; Horn DL
    Pediatr Infect Dis J; 1999 Dec; 18(12):1069-72. PubMed ID: 10608626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology, antimicrobial susceptibility, and characterization of fluoroquinolone non-susceptible Streptococcus pyogenes in Japan.
    Tatara K; Gotoh K; Okumiya K; Teramachi M; Ishimoto K; Tanaka Y; Iwahashi J; Shindou S; Yamashita Y; Watanabe H
    J Infect Chemother; 2020 Mar; 26(3):280-284. PubMed ID: 31680034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrolide resistance in Peptostreptococcus spp. mediated by ermTR: possible source of macrolide-lincosamide-streptogramin B resistance in Streptococcus pyogenes.
    Reig M; Galan J; Baquero F; Perez-Diaz JC
    Antimicrob Agents Chemother; 2001 Feb; 45(2):630-2. PubMed ID: 11158770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain.
    Perez-Trallero E; Urbieta M; Montes M; Ayestaran I; Marimon JM
    Eur J Clin Microbiol Infect Dis; 1998 Jan; 17(1):25-31. PubMed ID: 9512178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of macrolide and fluoroquinolone resistance with molecular typing in Streptococcus pyogenes from invasive infections, 2010-2012.
    Wajima T; Morozumi M; Chiba N; Shouji M; Iwata S; Sakata H; Ubukata K
    Int J Antimicrob Agents; 2013 Nov; 42(5):447-9. PubMed ID: 23988719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stepwise acquisition of multiple drug resistance by beta-hemolytic streptococci and difference in resistance pattern by type.
    Miyamoto Y; Takizawa K; Matsushima A; Asai Y; Nakatsuka S
    Antimicrob Agents Chemother; 1978 Mar; 13(3):399-404. PubMed ID: 400820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Distribution of emm genotypes and antibiotic susceptibility of Streptococcus pyogenes strains: analogy with the vaccine in development].
    Arslan U; Oryaşın E; Eskin Z; Türk Dağı H; Fındık D; Tuncer I; Bozdoğan B
    Mikrobiyol Bul; 2013 Apr; 47(2):318-23. PubMed ID: 23621731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections.
    Ikebe T; Hirasawa K; Suzuki R; Isobe J; Tanaka D; Katsukawa C; Kawahara R; Tomita M; Ogata K; Endoh M; Okuno R; Watanabe H
    Antimicrob Agents Chemother; 2005 Feb; 49(2):788-90. PubMed ID: 15673769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.